{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:55:19Z","timestamp":1791305719637,"version":"4.3.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-11151-6","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:21:15Z","timestamp":1791303675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-derived lactic acid as a potential upstream contributor to tumor hypoxia"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-6748","authenticated-orcid":false,"given":"Ning","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-8591","authenticated-orcid":false,"given":"Yuzhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"11151_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1203\/00006450-200105000-00002","volume":"49","author":"GL Semenza","year":"2001","unstructured":"Semenza, G. L. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr. Res. 49, 614\u2013617 https:\/\/doi.org\/10.1203\/00006450-200105000-00002 (2001).","journal-title":"Pediatr. Res."},{"key":"11151_CR2","first-page":"E73","volume":"93","author":"C Brahimi-Horn","year":"2006","unstructured":"Brahimi-Horn, C. & Pouyss\u00e9gur, J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull. Cancer 93, E73\u2013E80 (2006).","journal-title":"Bull. Cancer"},{"key":"11151_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza, G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625\u2013634 https:\/\/doi.org\/10.1038\/onc.2009.441 (2010).","journal-title":"Oncogene"},{"key":"11151_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399\u2013408 https:\/\/doi.org\/10.1016\/j.cell.2012.01.021 (2012).","journal-title":"Cell"},{"key":"11151_CR5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891\u2013899 https:\/\/doi.org\/10.1038\/nrc1478 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"11151_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee, P., Chandel, N. S. & Simon, M. C. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat. Rev. Mol. Cell Biol. 21, 268\u2013283 https:\/\/doi.org\/10.1038\/s41580-020-0227-y (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"11151_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-4614-7411-1_28","volume":"789","author":"A Mayer","year":"2013","unstructured":"Mayer, A. & Vaupel, P. Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy? Adv. Exp. Med. Biol. 789, 203\u2013209 https:\/\/doi.org\/10.1007\/978-1-4614-7411-1_28 (2013).","journal-title":"Adv. Exp. Med. Biol."},{"key":"11151_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"C-H Chang","year":"2013","unstructured":"Chang, C.-H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239\u20131251 https:\/\/doi.org\/10.1016\/j.cell.2013.05.016 (2013).","journal-title":"Cell"},{"key":"11151_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","volume":"154","author":"K De Bock","year":"2013","unstructured":"De Bock, K. et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651\u2013663 https:\/\/doi.org\/10.1016\/j.cell.2013.06.037 (2013).","journal-title":"Cell"},{"key":"11151_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.stem.2016.08.008","volume":"19","author":"W Gu","year":"2016","unstructured":"Gu, W. et al. Glycolytic metabolism plays a functional role in regulating human pluripotent stem cell state. Cell Stem Cell 19, 476\u2013490 https:\/\/doi.org\/10.1016\/j.stem.2016.08.008 (2016).","journal-title":"Cell Stem Cell"},{"key":"11151_CR11","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.stem.2023.07.007","volume":"30","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Enhanced glycolysis-mediated energy production in alveolar stem cells is required for alveolar regeneration. Cell Stem Cell 30, 1028\u20131042 https:\/\/doi.org\/10.1016\/j.stem.2023.07.007 (2023).","journal-title":"Cell Stem Cell"},{"key":"11151_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong, Y., Tu, R., Liu, H. & Qing, G. Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat. Signal Transduct. Target. Ther. 5, 124 https:\/\/doi.org\/10.1038\/s41392-020-00235-2 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"11151_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02218-1","volume":"24","author":"Q Ma","year":"2025","unstructured":"Ma, Q., Zhang, W., Wu, K. & Shi, L. The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy. Mol. Cancer 24, 14 https:\/\/doi.org\/10.1186\/s12943-024-02218-1 (2025).","journal-title":"Mol. Cancer"},{"key":"11151_CR14","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1089\/thy.2023.0700","volume":"34","author":"SS Wen","year":"2024","unstructured":"Wen, S. S. et al. BRAF(V600E)\/p-ERK\/p-DRP1(Ser616) promotes tumor progression and reprogramming of glucose metabolism in papillary thyroid cancer. Thyroid 34, 1246\u20131259 https:\/\/doi.org\/10.1089\/thy.2023.0700 (2024).","journal-title":"Thyroid"},{"key":"11151_CR15","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/1078-0432.Ccr-07-4131","volume":"14","author":"JA Mayr","year":"2008","unstructured":"Mayr, J. A. et al. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin. Cancer Res. 14, 2270\u20132275 https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-4131 (2008).","journal-title":"Clin. Cancer Res."},{"key":"11151_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s43018-023-00721-w","volume":"5","author":"M Mahmood","year":"2024","unstructured":"Mahmood, M. et al. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma. Nat. Cancer 5, 659\u2013672 https:\/\/doi.org\/10.1038\/s43018-023-00721-w (2024).","journal-title":"Nat. Cancer"},{"key":"11151_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/07853890310018458","volume":"35","author":"PJ Pollard","year":"2003","unstructured":"Pollard, P. J., Wortham, N. C. & Tomlinson, I. P. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann. Med. 35, 632\u2013639 https:\/\/doi.org\/10.1080\/07853890310018458 (2003).","journal-title":"Ann. Med."},{"key":"11151_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.bbabio.2010.10.023","volume":"1807","author":"D Chandra","year":"2011","unstructured":"Chandra, D. & Singh, K. K. Genetic insights into OXPHOS defect and its role in cancer. Biochim. Biophys. Acta 1807, 620\u2013625 https:\/\/doi.org\/10.1016\/j.bbabio.2010.10.023 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"11151_CR19","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp. Mol. Med. 55, 1357\u20131370 https:\/\/doi.org\/10.1038\/s12276-023-01020-1 (2023).","journal-title":"Exp. Mol. Med."},{"key":"11151_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/s1476-5586(03)80005-2","volume":"5","author":"PA Schornack","year":"2003","unstructured":"Schornack, P. A. & Gillies, R. J. Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia 5, 135\u2013145 https:\/\/doi.org\/10.1016\/s1476-5586(03)80005-2 (2003).","journal-title":"Neoplasia"},{"key":"11151_CR21","first-page":"410","volume":"47","author":"LM Cher","year":"2006","unstructured":"Cher, L. M. et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J. Nucl. Med. 47, 410\u2013418 (2006).","journal-title":"J. Nucl. Med."},{"key":"11151_CR22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 https:\/\/doi.org\/10.1126\/science.1160809 (2009).","journal-title":"Science"},{"key":"11151_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V. & Locasale, J. W. The Warburg effect: how does it benefit cancer cells? Trends Biochem. Sci. 41, 211\u2013218 https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"11151_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54435-3","volume":"15","author":"K G\u0142owacka","year":"2024","unstructured":"G\u0142owacka, K. et al. Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources. Nat. Commun. 15, 10107 https:\/\/doi.org\/10.1038\/s41467-024-54435-3 (2024).","journal-title":"Nat. Commun."},{"key":"11151_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.adp7603","volume":"390","author":"S Groessl","year":"2025","unstructured":"Groessl, S. et al. Acidosis orchestrates adaptations of energy metabolism in tumors. Science 390, eadp7603 https:\/\/doi.org\/10.1126\/science.adp7603 (2025).","journal-title":"Science"},{"key":"11151_CR26","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1073\/pnas.0502267102","volume":"102","author":"A Ramanathan","year":"2005","unstructured":"Ramanathan, A., Wang, C. & Schreiber, S. L. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. USA 102, 5992\u20135997 https:\/\/doi.org\/10.1073\/pnas.0502267102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11151_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang, C. V. MYC on the path to cancer. Cell 149, 22\u201335 https:\/\/doi.org\/10.1016\/j.cell.2012.03.003 (2012).","journal-title":"Cell"},{"key":"11151_CR28","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1073\/pnas.94.13.6658","volume":"94","author":"H Shim","year":"1997","unstructured":"Shim, H. et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94, 6658\u20136663 https:\/\/doi.org\/10.1073\/pnas.94.13.6658 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11151_CR29","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1126\/science.1174229","volume":"325","author":"J Yun","year":"2009","unstructured":"Yun, J. et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325, 1555\u20131559 https:\/\/doi.org\/10.1126\/science.1174229 (2009).","journal-title":"Science"},{"key":"11151_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying, H. et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149, 656\u2013670 https:\/\/doi.org\/10.1016\/j.cell.2012.01.058 (2012).","journal-title":"Cell"},{"key":"11151_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar, M. E., Kim, H. J. & Kim, D. R. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct. Target. Ther. 8, 455 https:\/\/doi.org\/10.1038\/s41392-023-01705-z (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"11151_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nbd.2011.06.007","volume":"44","author":"A Wolf","year":"2011","unstructured":"Wolf, A., Agnihotri, S., Munoz, D. & Guha, A. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme. Neurobiol. Dis. 44, 84\u201391 https:\/\/doi.org\/10.1016\/j.nbd.2011.06.007 (2011).","journal-title":"Neurobiol. Dis."},{"key":"11151_CR33","doi-asserted-by":"publisher","first-page":"41798","DOI":"10.18632\/oncotarget.9723","volume":"7","author":"HG Lee","year":"2016","unstructured":"Lee, H. G. et al. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma. Oncotarget 7, 41798\u201341810 https:\/\/doi.org\/10.18632\/oncotarget.9723 (2016).","journal-title":"Oncotarget"},{"key":"11151_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/onc.2009.332","volume":"29","author":"X Liu","year":"2010","unstructured":"Liu, X. et al. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene 29, 442\u2013450 https:\/\/doi.org\/10.1038\/onc.2009.332 (2010).","journal-title":"Oncogene"},{"key":"11151_CR35","doi-asserted-by":"publisher","unstructured":"Marco-Brualla, J. et al. Mutations in the ND2 subunit of mitochondrial complex I are sufficient to confer increased tumorigenic and metastatic potential to cancer cells. Cancers 11 https:\/\/doi.org\/10.3390\/cancers11071027 (2019).","DOI":"10.3390\/cancers11071027"},{"key":"11151_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","volume":"20","author":"WH Tong","year":"2011","unstructured":"Tong, W. H. et al. The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell 20, 315\u2013327 https:\/\/doi.org\/10.1016\/j.ccr.2011.07.018 (2011).","journal-title":"Cancer Cell"},{"key":"11151_CR37","doi-asserted-by":"publisher","first-page":"e7094","DOI":"10.1371\/journal.pone.0007094","volume":"4","author":"J Favier","year":"2009","unstructured":"Favier, J. et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE 4, e7094 https:\/\/doi.org\/10.1371\/journal.pone.0007094 (2009).","journal-title":"PLoS ONE"},{"key":"11151_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak, M. A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77\u201385 https:\/\/doi.org\/10.1016\/j.ccr.2004.11.022 (2005).","journal-title":"Cancer Cell"},{"key":"11151_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs, J. S. et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143\u2013153 https:\/\/doi.org\/10.1016\/j.ccr.2005.06.017 (2005).","journal-title":"Cancer Cell"},{"key":"11151_CR40","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard, P. J. et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1\u03b1 in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231\u20132239 https:\/\/doi.org\/10.1093\/hmg\/ddi227 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"11151_CR41","doi-asserted-by":"publisher","unstructured":"Esteban-Amo, M. J., Jim\u00e9nez-Cuadrado, P., Serrano-Lorenzo, P., de la Fuente, M. & Simarro, M. Succinate dehydrogenase and human disease: novel insights into a well-known enzyme. Biomedicines 12 https:\/\/doi.org\/10.3390\/biomedicines12092050 (2024).","DOI":"10.3390\/biomedicines12092050"},{"key":"11151_CR42","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1158\/0008-5472.Can-20-2936","volume":"81","author":"J Goncalves","year":"2021","unstructured":"Goncalves, J. et al. Loss of SDHB promotes dysregulated iron homeostasis, oxidative stress, and sensitivity to ascorbate. Cancer Res. 81, 3480\u20133494 https:\/\/doi.org\/10.1158\/0008-5472.Can-20-2936 (2021).","journal-title":"Cancer Res."},{"key":"11151_CR43","doi-asserted-by":"publisher","unstructured":"Guo, Q. et al. Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage. Endocr. Relat. Cancer 33 https:\/\/doi.org\/10.1530\/ERC-25-0397 (2026).","DOI":"10.1530\/ERC-25-0397"},{"key":"11151_CR44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cancergen.2012.05.001","volume":"205","author":"Y Yang","year":"2012","unstructured":"Yang, Y. et al. A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet. 205, 377\u2013390 https:\/\/doi.org\/10.1016\/j.cancergen.2012.05.001 (2012).","journal-title":"Cancer Genet."},{"key":"11151_CR45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.celrep.2017.09.092","volume":"21","author":"PA Tyrakis","year":"2017","unstructured":"Tyrakis, P. A. et al. Fumarate hydratase loss causes combined respiratory chain defects. Cell Rep. 21, 1036\u20131047 https:\/\/doi.org\/10.1016\/j.celrep.2017.09.092 (2017).","journal-title":"Cell Rep."},{"key":"11151_CR46","doi-asserted-by":"publisher","unstructured":"Crooks, D. R. et al. Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer. Sci. Signal. 14 https:\/\/doi.org\/10.1126\/scisignal.abc4436 (2021).","DOI":"10.1126\/scisignal.abc4436"},{"key":"11151_CR47","doi-asserted-by":"publisher","first-page":"24691","DOI":"10.1074\/jbc.M114.568162","volume":"289","author":"K Shanmugasundaram","year":"2014","unstructured":"Shanmugasundaram, K. et al. The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-\u03baB signaling. J. Biol. Chem. 289, 24691\u201324699 https:\/\/doi.org\/10.1074\/jbc.M114.568162 (2014).","journal-title":"J. Biol. Chem."},{"key":"11151_CR48","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","volume":"20","author":"J Adam","year":"2011","unstructured":"Adam, J. et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524\u2013537 https:\/\/doi.org\/10.1016\/j.ccr.2011.09.006 (2011).","journal-title":"Cancer Cell"},{"key":"11151_CR49","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao, M. et al. Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326\u20131338 https:\/\/doi.org\/10.1101\/gad.191056.112 (2012).","journal-title":"Genes Dev."},{"key":"11151_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2013.05.015","volume":"23","author":"M Yang","year":"2013","unstructured":"Yang, M. & Pollard, P. J. Succinate: a new epigenetic hacker. Cancer Cell 23, 709\u2013711 https:\/\/doi.org\/10.1016\/j.ccr.2013.05.015 (2013).","journal-title":"Cancer Cell"},{"key":"11151_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7497\/j.issn.2095-3941.2014.01.001","volume":"11","author":"LM Phan","year":"2014","unstructured":"Phan, L. M., Yeung, S. C. & Lee, M. H. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol. Med. 11, 1\u201319 https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2014.01.001 (2014).","journal-title":"Cancer Biol. Med."},{"key":"11151_CR52","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta, S. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916\u2013921 (2000).","journal-title":"Cancer Res."},{"key":"11151_CR53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3892\/ijo.2011.1055","volume":"39","author":"K Goetze","year":"2011","unstructured":"Goetze, K., Walenta, S., Ksiazkiewicz, M., Kunz-Schughart, L. A. & Mueller-Klieser, W. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int. J. Oncol. 39, 453\u2013463 https:\/\/doi.org\/10.3892\/ijo.2011.1055 (2011).","journal-title":"Int. J. Oncol."},{"key":"11151_CR54","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/cphy.c130008","volume":"3","author":"AP Halestrap","year":"2013","unstructured":"Halestrap, A. P. Monocarboxylic acid transport. Compr. Physiol. 3, 1611\u20131643 https:\/\/doi.org\/10.1002\/cphy.c130008 (2013).","journal-title":"Compr. Physiol."},{"key":"11151_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28558-4","volume":"13","author":"A Yamaguchi","year":"2023","unstructured":"Yamaguchi, A. et al. Monocarboxylate transporter 4 involves in energy metabolism and drug sensitivity in hypoxia. Sci. Rep. 13, 1501 https:\/\/doi.org\/10.1038\/s41598-023-28558-4 (2023).","journal-title":"Sci. Rep."},{"key":"11151_CR56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.4562","volume":"237","author":"F Baenke","year":"2015","unstructured":"Baenke, F. et al. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival. J. Pathol. 237, 152\u2013165 https:\/\/doi.org\/10.1002\/path.4562 (2015).","journal-title":"J. Pathol."},{"key":"11151_CR57","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1158\/1078-0432.Ccr-13-1180","volume":"19","author":"P Fisel","year":"2013","unstructured":"Fisel, P. et al. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome. Clin. Cancer Res. 19, 5170\u20135181 https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-1180 (2013).","journal-title":"Clin. Cancer Res."},{"key":"11151_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen, V. L., Mina, E., Van H\u00e9e, V. F., Porporato, P. E. & Sonveaux, P. Monocarboxylate transporters in cancer. Mol. Metab. 33, 48\u201366 https:\/\/doi.org\/10.1016\/j.molmet.2019.07.006 (2020).","journal-title":"Mol. Metab."},{"key":"11151_CR59","doi-asserted-by":"publisher","first-page":"20135","DOI":"10.1074\/jbc.RA119.009093","volume":"294","author":"Y Contreras-Baeza","year":"2019","unstructured":"Contreras-Baeza, Y. et al. Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments. J. Biol. Chem. 294, 20135\u201320147 https:\/\/doi.org\/10.1074\/jbc.RA119.009093 (2019).","journal-title":"J. Biol. Chem."},{"key":"11151_CR60","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.4161\/cc.10.11.15659","volume":"10","author":"D Whitaker-Menezes","year":"2011","unstructured":"Whitaker-Menezes, D. et al. Evidence for a stromal-epithelial \u201clactate shuttle\u201d in human tumors. Cell Cycle 10, 1772\u20131783 https:\/\/doi.org\/10.4161\/cc.10.11.15659 (2011).","journal-title":"Cell Cycle"},{"key":"11151_CR61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0092-8674(89)90901-X","volume":"56","author":"C Sardet","year":"1989","unstructured":"Sardet, C., Franchi, A. & Pouyss\u00e9gur, J. Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+H+ antiporter. Cell 56, 271\u2013280 https:\/\/doi.org\/10.1016\/0092-8674(89)90901-X (1989).","journal-title":"Cell"},{"key":"11151_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","volume":"26","author":"P Swietach","year":"2007","unstructured":"Swietach, P., Vaughan-Jones, R. D. & Harris, A. L. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 26, 299\u2013310 https:\/\/doi.org\/10.1007\/s10555-007-9064-0 (2007).","journal-title":"Cancer Metastasis Rev."},{"key":"11151_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.37349\/etat.2020.00005","volume":"1","author":"C Ward","year":"2020","unstructured":"Ward, C. et al. The impact of tumour pH on cancer progression: strategies for clinical intervention. Explor. Target. Antitumor Ther. 1, 71\u2013100 https:\/\/doi.org\/10.37349\/etat.2020.00005 (2020).","journal-title":"Explor. Target. Antitumor Ther."},{"key":"11151_CR64","doi-asserted-by":"publisher","first-page":"135","DOI":"10.37349\/etat.2024.00210","volume":"5","author":"T Koltai","year":"2024","unstructured":"Koltai, T. & Fliegel, L. Exploring monocarboxylate transporter inhibition for cancer treatment. Explor. Target. Antitumor Ther. 5, 135\u2013169 https:\/\/doi.org\/10.37349\/etat.2024.00210 (2024).","journal-title":"Explor. Target. Antitumor Ther."},{"key":"11151_CR65","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/path.4218","volume":"230","author":"SY Choi","year":"2013","unstructured":"Choi, S. Y., Collins, C. C., Gout, P. W. & Wang, Y. Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J. Pathol. 230, 350\u2013355 https:\/\/doi.org\/10.1002\/path.4218 (2013).","journal-title":"J. Pathol."},{"key":"11151_CR66","doi-asserted-by":"publisher","unstructured":"Wang, J. X. et al. Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21218363 (2020).","DOI":"10.3390\/ijms21218363"},{"key":"11151_CR67","doi-asserted-by":"publisher","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006 (2016).","DOI":"10.1016\/j.cmet.2015.12.006"},{"key":"11151_CR68","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559\u2013563 https:\/\/doi.org\/10.1038\/nature13490 (2014).","journal-title":"Nature"},{"key":"11151_CR69","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41556-025-01839-y","volume":"28","author":"D Li","year":"2026","unstructured":"Li, D. et al. Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastoma. Nat. Cell Biol. 28, 349\u2013362 https:\/\/doi.org\/10.1038\/s41556-025-01839-y (2026).","journal-title":"Nat. Cell Biol."},{"key":"11151_CR70","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/s42255-025-01331-9","volume":"7","author":"M Certo","year":"2025","unstructured":"Certo, M. et al. Lactate signalling leads to aggregation of immune-inflammatory hotspots and SLC5A12 blockade promotes their resolution. Nat. Metab. 7, 1663\u20131680 https:\/\/doi.org\/10.1038\/s42255-025-01331-9 (2025).","journal-title":"Nat. Metab."},{"key":"11151_CR71","doi-asserted-by":"publisher","first-page":"e0152789","DOI":"10.1371\/journal.pone.0152789","volume":"11","author":"Z Jing","year":"2016","unstructured":"Jing, Z. et al. The proton-sensing G-protein coupled receptor GPR4 promotes angiogenesis in head and neck cancer. PLoS ONE 11, e0152789 https:\/\/doi.org\/10.1371\/journal.pone.0152789 (2016).","journal-title":"PLoS ONE"},{"key":"11151_CR72","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng, J. Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol. Lett. 4, 1151\u20131157 https:\/\/doi.org\/10.3892\/ol.2012.928 (2012).","journal-title":"Oncol. Lett."},{"key":"11151_CR73","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Tom\u00e1s, R. & P\u00e9rez-Guill\u00e9n, I. Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers 12 https:\/\/doi.org\/10.3390\/cancers12113244 (2020).","DOI":"10.3390\/cancers12113244"},{"key":"11151_CR74","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/wound.2013.0517","volume":"3","author":"KE Johnson","year":"2014","unstructured":"Johnson, K. E. & Wilgus, T. A. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv. Wound Care 3, 647\u2013661 https:\/\/doi.org\/10.1089\/wound.2013.0517 (2014).","journal-title":"Adv. Wound Care"},{"key":"11151_CR75","doi-asserted-by":"publisher","first-page":"86026","DOI":"10.18632\/oncotarget.13323","volume":"7","author":"S Faes","year":"2016","unstructured":"Faes, S. et al. Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies. Oncotarget 7, 86026\u201386038 https:\/\/doi.org\/10.18632\/oncotarget.13323 (2016).","journal-title":"Oncotarget"},{"key":"11151_CR76","doi-asserted-by":"publisher","first-page":"e61991","DOI":"10.1371\/journal.pone.0061991","volume":"8","author":"L Dong","year":"2013","unstructured":"Dong, L. et al. Acidosis activation of the proton-sensing GPR4 receptor stimulates vascular endothelial cell inflammatory responses revealed by transcriptome analysis. PLoS ONE 8, e61991 https:\/\/doi.org\/10.1371\/journal.pone.0061991 (2013).","journal-title":"PLoS ONE"},{"key":"11151_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.100848","volume":"23","author":"EA Krewson","year":"2020","unstructured":"Krewson, E. A. et al. The proton-sensing GPR4 receptor regulates paracellular gap formation and permeability of vascular endothelial cells. iScience 23, 100848 https:\/\/doi.org\/10.1016\/j.isci.2020.100848 (2020).","journal-title":"iScience"},{"key":"11151_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/cvr\/cvp105","volume":"83","author":"M Asai","year":"2009","unstructured":"Asai, M. et al. Extracellular acidosis suppresses endothelial function by inhibiting store-operated Ca2+ entry via non-selective cation channels. Cardiovasc. Res. 83, 97\u2013105 https:\/\/doi.org\/10.1093\/cvr\/cvp105 (2009).","journal-title":"Cardiovasc. Res."},{"key":"11151_CR79","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jcrc.2011.06.001","volume":"27","author":"E Crimi","year":"2012","unstructured":"Crimi, E. et al. Effects of intracellular acidosis on endothelial function: an overview. J. Crit. Care 27, 108\u2013118 https:\/\/doi.org\/10.1016\/j.jcrc.2011.06.001 (2012).","journal-title":"J. Crit. Care"},{"key":"11151_CR80","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.molmed.2020.11.006","volume":"27","author":"L Claesson-Welsh","year":"2021","unstructured":"Claesson-Welsh, L., Dejana, E. & McDonald, D. M. Permeability of the endothelial barrier: identifying and reconciling controversies. Trends Mol. Med. 27, 314\u2013331 https:\/\/doi.org\/10.1016\/j.molmed.2020.11.006 (2021).","journal-title":"Trends Mol. Med."},{"key":"11151_CR81","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jtbi.2012.11.031","volume":"320","author":"M Wu","year":"2013","unstructured":"Wu, M. et al. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J. Theor. Biol. 320, 131\u2013151 https:\/\/doi.org\/10.1016\/j.jtbi.2012.11.031 (2013).","journal-title":"J. Theor. Biol."},{"key":"11151_CR82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.semcancer.2017.01.008","volume":"43","author":"I Kolosenko","year":"2017","unstructured":"Kolosenko, I., Avnet, S., Baldini, N., Viklund, J. & De Milito, A. Therapeutic implications of tumor interstitial acidification. Semin. Cancer Biol. 43, 119\u2013133 https:\/\/doi.org\/10.1016\/j.semcancer.2017.01.008 (2017).","journal-title":"Semin. Cancer Biol."},{"key":"11151_CR83","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2019","unstructured":"Henke, E., Nandigama, R. & Erg\u00fcn, S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front. Mol. Biosci. 6, 160 https:\/\/doi.org\/10.3389\/fmolb.2019.00160 (2019).","journal-title":"Front. Mol. Biosci."},{"key":"11151_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-026-02992-5","volume":"12","author":"X Bao","year":"2026","unstructured":"Bao, X. et al. Absolute dynamic and relative static: the relationship of glycolysis and OXPHOS in cancer development. Cell Death Discov. 12, 136 https:\/\/doi.org\/10.1038\/s41420-026-02992-5 (2026).","journal-title":"Cell Death Discov."},{"key":"11151_CR85","doi-asserted-by":"publisher","unstructured":"Grasmann, G., Mondal, A. & Leithner, K. Flexibility and adaptation of cancer cells in a heterogenous metabolic microenvironment. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22031476 (2021).","DOI":"10.3390\/ijms22031476"},{"key":"11151_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110493","volume":"38","author":"J Michl","year":"2022","unstructured":"Michl, J. et al. CRISPR-Cas9 screen identifies oxidative phosphorylation as essential for cancer cell survival at low extracellular pH. Cell Rep. 38, 110493 https:\/\/doi.org\/10.1016\/j.celrep.2022.110493 (2022).","journal-title":"Cell Rep."},{"key":"11151_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2023.05.097","volume":"671","author":"S Zeng","year":"2023","unstructured":"Zeng, S. & Hu, X. Lactic acidosis switches cancer cells from dependence on glycolysis to OXPHOS and renders them highly sensitive to OXPHOS inhibitors. Biochem. Biophys. Res. Commun. 671, 46\u201357 https:\/\/doi.org\/10.1016\/j.bbrc.2023.05.097 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"11151_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan, D., Braganza, A. & Shiva, S. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 37, 101674 https:\/\/doi.org\/10.1016\/j.redox.2020.101674 (2020).","journal-title":"Redox Biol."},{"key":"11151_CR89","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 https:\/\/doi.org\/10.1038\/s41586-019-1678-1 (2019).","journal-title":"Nature"},{"key":"11151_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01898-4","volume":"10","author":"S Wei","year":"2024","unstructured":"Wei, S. et al. Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K\/AKT\/HIF-1\u03b1 signal pathway in endometrial carcinoma. Cell Death Discov. 10, 121 https:\/\/doi.org\/10.1038\/s41420-024-01898-4 (2024).","journal-title":"Cell Death Discov."},{"key":"11151_CR91","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1172\/jci36843","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux, P. et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Investig. 118, 3930\u20133942 https:\/\/doi.org\/10.1172\/jci36843 (2008).","journal-title":"J. Clin. Investig."},{"key":"11151_CR92","doi-asserted-by":"publisher","first-page":"e46571","DOI":"10.1371\/journal.pone.0046571","volume":"7","author":"CJ De Saedeleer","year":"2012","unstructured":"De Saedeleer, C. J. et al. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS ONE 7, e46571 https:\/\/doi.org\/10.1371\/journal.pone.0046571 (2012).","journal-title":"PLoS ONE"},{"key":"11151_CR93","doi-asserted-by":"publisher","first-page":"23111","DOI":"10.1074\/jbc.M202487200","volume":"277","author":"H Lu","year":"2002","unstructured":"Lu, H., Forbes, R. A. & Verma, A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis*. J. Biol. Chem. 277, 23111\u201323115 https:\/\/doi.org\/10.1074\/jbc.M202487200 (2002).","journal-title":"J. Biol. Chem."},{"key":"11151_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02366-x","volume":"23","author":"C Li","year":"2025","unstructured":"Li, C. et al. Lactylation modification of HIF-1\u03b1 enhances its stability by blocking VHL recognition. Cell Commun. Signal. 23, 364 https:\/\/doi.org\/10.1186\/s12964-025-02366-x (2025).","journal-title":"Cell Commun. Signal."},{"key":"11151_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.594200","volume":"11","author":"J Coronel-Hern\u00e1ndez","year":"2021","unstructured":"Coronel-Hern\u00e1ndez, J. et al. Combination of metformin, sodium oxamate and doxorubicin induces apoptosis and autophagy in colorectal cancer cells via downregulation HIF-1\u03b1. Front. Oncol. 11, 594200 https:\/\/doi.org\/10.3389\/fonc.2021.594200 (2021).","journal-title":"Front. Oncol."},{"key":"11151_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2014.11.046","volume":"358","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z., Han, F., Yang, S., Wu, J. & Zhan, W. Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt-mTOR signaling pathway. Cancer Lett. 358, 17\u201326 https:\/\/doi.org\/10.1016\/j.canlet.2014.11.046 (2015).","journal-title":"Cancer Lett."},{"key":"11151_CR97","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/1535-7163.Mct-18-0107","volume":"17","author":"T Todenh\u00f6fer","year":"2018","unstructured":"Todenh\u00f6fer, T. et al. Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer. Mol. Cancer Ther. 17, 2746\u20132755 https:\/\/doi.org\/10.1158\/1535-7163.Mct-18-0107 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"11151_CR98","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1002\/cam4.1587","volume":"7","author":"SYC Choi","year":"2018","unstructured":"Choi, S. Y. C. et al. Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer. Cancer Med. 7, 3385\u20133392 https:\/\/doi.org\/10.1002\/cam4.1587 (2018).","journal-title":"Cancer Med."},{"key":"11151_CR99","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13018-023-03623-w","volume":"18","author":"G Sheng","year":"2023","unstructured":"Sheng, G., Gao, Y., Wu, H., Liu, Y. & Yang, Y. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis. J. Orthop. Surg. Res. 18, 131 https:\/\/doi.org\/10.1186\/s13018-023-03623-w (2023).","journal-title":"J. Orthop. Surg. Res."},{"key":"11151_CR100","doi-asserted-by":"publisher","unstructured":"Br\u00e4utigam, K. et al. Dual inhibition of lactate transporters MCT1 and MCT4 in pancreatic neuroendocrine tumors targets metabolic heterogeneity and functional redundancy. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.01.31.635625 (2025).","DOI":"10.1101\/2025.01.31.635625"},{"key":"11151_CR101","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","volume":"25","author":"D Benjamin","year":"2018","unstructured":"Benjamin, D. et al. Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells. Cell Rep. 25, 3047\u20133058 https:\/\/doi.org\/10.1016\/j.celrep.2018.11.043 (2018).","journal-title":"Cell Rep."},{"key":"11151_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1175563","volume":"13","author":"M Hosonuma","year":"2023","unstructured":"Hosonuma, M. & Yoshimura, K. Association between pH regulation of the tumor microenvironment and immunological state. Front. Oncol. 13, 1175563 https:\/\/doi.org\/10.3389\/fonc.2023.1175563 (2023).","journal-title":"Front. Oncol."},{"key":"11151_CR103","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41416-019-0717-x","volume":"122","author":"M Beloueche-Babari","year":"2020","unstructured":"Beloueche-Babari, M. et al. Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration. Br. J. Cancer 122, 895\u2013903 https:\/\/doi.org\/10.1038\/s41416-019-0717-x (2020).","journal-title":"Br. J. Cancer"},{"key":"11151_CR104","doi-asserted-by":"publisher","unstructured":"Babl, N. et al. MCT4 blockade increases the efficacy of immune checkpoint blockade. J. Immunother. Cancer 11 https:\/\/doi.org\/10.1136\/jitc-2023-007349 (2023).","DOI":"10.1136\/jitc-2023-007349"},{"key":"11151_CR105","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ymthe.2024.12.044","volume":"33","author":"W Oh","year":"2025","unstructured":"Oh, W., Kim, A. M. J., Dhawan, D., Knapp, D. W. & Lim, S. O. Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1\/PD-L1 blockade therapy-resistant tumor. Mol. Ther. 33, 723\u2013733 https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.044 (2025).","journal-title":"Mol. Ther."},{"key":"11151_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2026.168308","volume":"1872","author":"L Yang","year":"2026","unstructured":"Yang, L. et al. Syrosingopine enhances immune checkpoint blockade efficacy by inhibition of MCTs and metabolic reprogramming in triple-negative breast cancer. Biochim. Biophys. Acta 1872, 168308 https:\/\/doi.org\/10.1016\/j.bbadis.2026.168308 (2026).","journal-title":"Biochim. Biophys. Acta"},{"key":"11151_CR107","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1073\/pnas.1808950116","volume":"116","author":"C Sun","year":"2019","unstructured":"Sun, C. et al. Spatially resolved metabolomics to discover tumor-associated metabolic alterations. Proc. Natl. Acad. Sci. USA 116, 52\u201357 https:\/\/doi.org\/10.1073\/pnas.1808950116 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11151_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43917-5","volume":"14","author":"T Hu","year":"2023","unstructured":"Hu, T. et al. Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology. Nat. Commun. 14, 8260 https:\/\/doi.org\/10.1038\/s41467-023-43917-5 (2023).","journal-title":"Nat. Commun."},{"key":"11151_CR109","doi-asserted-by":"publisher","unstructured":"Perez, R. C., Kim, D., Maxwell, A. W. P. & Camacho, J. C. Functional imaging of hypoxia: PET and MRI. Cancers 15 https:\/\/doi.org\/10.3390\/cancers15133336 (2023).","DOI":"10.3390\/cancers15133336"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-11151-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-11151-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-11151-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:21:19Z","timestamp":1791303679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-11151-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11151"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-11151-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1298"}}